Similarly, the gene mutation landscape of the GDSC-CRC cell line also suggested that except for APC, TP53, and KRAS, the remaining genes with the top 20 mutation frequencies were more likely to be mutated in the MSI-H group than in the MSS/MSI-L group (Supplementary Figure S2A). This evidence concerns the gene KRAS and colorectal carcinoma.